Rapamycin in 2026: What the Latest Longevity Trials Actually Show

Intermittent low-dose rapamycin keeps producing the most consistent lifespan signal of any drug tested in mammals. Here is what the 2026 data adds, and how serious longevity protocols are evolving.
Rapamycin remains the single most replicated pro-longevity intervention in mammals. In 2026 the conversation has shifted from "does it work?" to "what is the right intermittent dose for humans who want more healthy years?".